$33 million cash in the bank, zero debt, and in Q1 cash flow positive to the tune of $2.9 million.
The CEO has signalled he thinks the company is undervalued.
GSS could pay a dividend of 1 cps twice yearly at a cost of about $2.9 million per year or half a cent at a cost of $1.4 million.
The Board should be proactive, not passive, and use its strong balance sheet to the advantage of shareholders. It would also back up in actions the confidence that it routinely expresses in words.
It would still retain more than sufficient funds for investment in growth.
A little bit more financial acumen is in order and attention to shareholders. The balance sheet should be made to work harder.
- Forums
- ASX - By Stock
- GSS
- Time for a dividend
GSS
genetic signatures limited
Add to My Watchlist
2.67%
!
36.5¢

Time for a dividend
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $160 | 438 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19601 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 32411 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14601 | 0.365 |
2 | 9513 | 0.360 |
3 | 30509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 32411 | 1 |
0.380 | 3086 | 1 |
0.390 | 20000 | 1 |
0.395 | 5000 | 1 |
0.400 | 111918 | 2 |
Last trade - 13.38pm 04/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online